Saitama-ken, Japan

Akihiko Kusunoki


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akihiko Kusunoki: Innovator in Skin Patch Technology

Introduction

Akihiko Kusunoki is a notable inventor based in Saitama-ken, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of skin patch compositions. His innovative work has led to the creation of a unique formulation that enhances the efficacy of skin patches.

Latest Patents

Kusunoki holds a patent for a composition for skin patch preparation and the process for preparing the same. This composition includes a synthetic polymer gel created by reacting a water-soluble polymer of an aliphatic carboxylic acid or a salt thereof with a sparingly soluble aluminum compound. Additionally, it incorporates an organic acid containing a hydroxyl group as a reaction accelerator and an ethylenediamine compound as a reaction inhibitor, all in the presence of water at a pH of 4.0 to 6.1. This innovative composition can homogeneously gel at any crosslinking rate and maintains its quality over time, making it a valuable advancement in the field.

Career Highlights

Kusunoki is currently associated with Saitama Daiichi Pharmaceutical Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in polymer chemistry and formulation development has positioned him as a key player in the industry.

Collaborations

Throughout his career, Kusunoki has collaborated with talented individuals such as Naohisa Kawamura and Yoshiki Sugizaki. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Akihiko Kusunoki's contributions to skin patch technology exemplify the impact of innovative thinking in the pharmaceutical industry. His patented composition represents a significant advancement that could enhance patient care and treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…